Bronchoscopic lung volume reduction with one-way endobronchial valves is a guideline
treatment option for patients with advanced emphysema, supported by extensive scientific …

COPD is the fourth leading cause of death in the United States and is a serious respiratory
illness characterized by years of progressively debilitating breathlessness, high prevalence …

Background Chronic non‐invasive ventilation (NIV) is increasingly being used to treat
people with COPD who have respiratory failure, but the evidence supporting this treatment …

Inhalation is a non-invasive method of local drug delivery to the respiratory system. This
study analyzed the potential use of aqueous dispersion of oxygen nanobubbles (ADON) as …

Introduction COPD is one of the most common pulmonary diseases and one of the leading
causes of death worldwide. Exacerbations of COPD include acute worsening that could lead …

Introduction One-way endobronchial valve treatment improves lung function, exercise
capacity, and quality of live in patients with severe emphysema and hyperinflation. Other …

Home ventilation for patients with end-stage chronic obstruc... : Current Opinion in
Supportive and Palliative Care Home ventilation for patients with end-stage chronic …

The well-recognized individual heterogeneity within COPD patients has led to a growing
interest in greater personalization in the approach of these patients. Thus, the treatable traits …

Bronchoscopic lung volume reduction treatment with Zephyr one-way valves is an effective
guideline-based treatment option for patients with severe emphysema and hyperinflation …

Chronic respiratory diseases are major contributors to the global burden of disease. While
understanding of these diseases has improved, treatment guidelines have continued to rely …